Single-injection Adductor Canal Block for Total Knee Arthroplasty Under Spinal Anesthesia
The Effect of Postoperative Single-injection Adductor Canal Block for Multimodal Pain Control in Patients Receiving Total Knee Arthroplasty Under Spinal Anesthesia
1 other identifier
interventional
80
1 country
1
Brief Summary
This study evaluates the effect of the single-injection adductor canal block in patients receiving total knee arthroplasty under spinal anesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2020
CompletedFirst Posted
Study publicly available on registry
May 22, 2020
CompletedStudy Start
First participant enrolled
May 28, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 22, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 29, 2021
CompletedNovember 24, 2023
November 1, 2023
1.1 years
May 19, 2020
November 21, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
the sum of pain score
VAS pain score (0 to 10) is measured using numeric pain rating scale at 2 hours, 6 hours, 12 hours, and 24 hours 0: no pain, 10: worst pain
2 hours, 6 hours, 12 hours, and 24 hours after intervention
Secondary Outcomes (2)
Postoperative nausea and vomiting
2 hours, 6 hours, 12 hours, and 24 hours after intervention
Postoperative opioid consumption
2 hours, 6 hours, 12 hours, and 24 hours intervention
Study Arms (2)
control group
SHAM COMPARATORnormal saline injection
test group
EXPERIMENTAL0.5% ropivacaine injection
Interventions
After the end of the surgery, at the arrival of PACU, the patient's leg is prepared and draped in a sterile manner. Assisted by the high-frequency linear ultrasound transducer, we target the mid-thigh level and the 22-gauge/8cm needle is introduced in plain through the sartorius muscle. the correct position for the tip of the needle in the adductor canal is checked and a bolus injection of 0.5% ropivacaine 15ml is given.
After the end of the surgery, at the arrival of PACU, the patient's leg is prepared and draped in a sterile manner. Assisted by the high-frequency linear ultrasound transducer, we target the mid-thigh level and the 22-gauge/8cm needle is introduced in plain through the sartorius muscle. the correct position for the tip of the needle in the adductor canal is checked and a bolus injection of normal saline15ml is given.
Eligibility Criteria
You may qualify if:
- adult patients receiving total-knee arthroplasty under spinal anesthesia
- ASA class 1-3
You may not qualify if:
- infection at the needle injection site
- hard for pain evaluation
- CRPS patient with lower extremity symptom
- chronic opioid user
- those with side effect to local anesthetics
- those getting revision total-knee arthroplasty or with the previous operation at the same knee area
- those getting the surgery under general anesthesia due to the failed spinal anesthesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Hospital
Seoul, 110-744, South Korea
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
May 19, 2020
First Posted
May 22, 2020
Study Start
May 28, 2020
Primary Completion
June 22, 2021
Study Completion
June 29, 2021
Last Updated
November 24, 2023
Record last verified: 2023-11